History

How the Story Changed

For five years management told one story — premium brand, low brand awareness equals long runway, double the company every five years. That story began cracking in Q1 FY2024 with what was first called a "color palette" miss in U.S. women's. By Q2 FY2025, the diagnosis had grown into something structural: the core franchises that built the brand — Scuba, Softstreme, Dance Studio — had become "stale," product life cycles had "run too long," and the Power of Three x2 revenue target ($12.5B by FY2026) was no longer reachable. Calvin McDonald announced his exit in December 2025. Founder Chip Wilson opened a proxy contest in March 2026. Credibility — built up over roughly 20 consecutive beat-and-raises — has been spent.

1. The Narrative Arc

The shape of this story is clear when you collapse it. From 2018–2023, McDonald executed a near-perfect growth playbook: tripled revenue, quadrupled international, built China into the second-largest market, reached $10B. Then a single weakness — U.S. women's — was diagnosed, mis-diagnosed, and re-diagnosed three times across six quarters before management conceded the problem was the core franchises, not just their colors.

The Power of Three x2 plan, set in 2022, called for $12,500M by FY2026. The FY2026 guidance midpoint is $11,425M. The gap is roughly $1.1B of unfulfilled promise — and the cause is concentrated in one geography (the U.S., now guided to decline) and one half of the assortment (lounge/social).

2. What Management Emphasized — and Then Stopped Emphasizing

Management Talk-Track: How Often Each Topic Appeared on Calls (0 = never, 5 = heavy).

What this shows in one image:

• "Power of Three x2" was the centerpiece of every call from FY2023 through Q1 FY2025. It is no longer mentioned in the most recent FY2026 guidance. The plan was quietly dropped without acknowledgment that it had been missed.
• "Newness" — a word almost absent in FY2023 — became the dominant noun on every call from Q1 FY2024 onward. It is the single word that defines the new era.
• MIRROR / lululemon Studio went from ~3 mentions per call to zero. The acquisition was effectively erased from the narrative.
• Operating margin expansion was a steady promise into FY2024. By FY2026 guidance (-250 bps), it is no longer claimed.

3. Risk Evolution

Risk Factor Emphasis in 10-K Filings (0 = absent, 5 = prominent).

The risk story is more honest than the equity story. Two new risks appeared in the FY2025 10-K that were essentially absent before:

• Tariffs and de minimis exemption removal — a single risk paragraph in earlier filings became one of the largest financial exposures the company has ever disclosed: ~$275M gross tariff cost in FY2025, ~$380M expected in FY2026. The de minimis change alone is ~170 bps of FY2025 gross margin because two-thirds of U.S. e-commerce orders shipped from Canada qualified for the exemption.
• Consumer political polarization / brand activism — the FY2025 10-K added explicit language about reputational risk regardless of whether the company takes positions. This is new vocabulary.

The risks that quietly disappeared are equally informative:

• MIRROR-specific risks were prominent in FY2021–FY2022, then folded into general acquisition risk after the impairment.
• COVID-specific operational risk has shrunk to a single paragraph on "public health crises."

The Taiwan fabric concentration disclosure has been stable but is increasingly load-bearing: ~34% of fabric still originates from Taiwan, with another 29% from China Mainland.

4. How They Handled Bad News

The U.S. women's slowdown is the test case. The diagnosis evolved across six quarters in a way that is worth tracking explicitly.

Each diagnosis was offered as the final answer. Each was undone within two quarters. The pattern matters more than any individual quarter:

• Q1 FY2024: The miss was framed as tactical (color, sizing) and self-inflicted ("within our control").
• Q2 FY2024: When the same problem re-appeared larger, the diagnosis upgraded to organizational — the product org structure itself was wrong. CPO Sun Choe departed.
• Q2 FY2025: A full year after the structural fix, the diagnosis upgraded again — this time to the franchises themselves. "We have let our product life cycles run too long."

This is the most important sentence in the post-2023 narrative, because it concedes that the brand's most-loved products had become its drag — exactly the opposite of what management had been describing for years.

The handling itself, judged narrowly: management was honest enough to upgrade the diagnosis publicly each time, and did not blame the consumer alone. They never claimed the prior diagnosis had been correct after revising it. That deserves credit. But the decision to call each new framing the "root cause" — three times — has a cost in credibility that future calls will carry.

5. Guidance Track Record

Three observations:

• FY2023 was the cleanest beat-and-raise year of the McDonald era. Initial guide was below ultimate delivery by ~9%. This is the high-water mark for credibility.
• FY2024 was the first cut. A maintained Q1 guide became a Q2 cut of roughly $400M of revenue and $0.30 of EPS — the first material walk-back in years.
• FY2025 broke the pattern. Initial $15.05 EPS guidance ended at $13.26 — a ~12% miss on the bottom line, half from organic deceleration in the U.S., half from tariffs/de minimis that emerged mid-year.
• The Power of Three x2 plan target ($12.5B by FY2026) will be missed by ~$1.1B based on the current FY2026 guide. The plan was not formally retracted; it was simply stopped being mentioned.

Credibility score: 5/10. Not lower because: the diagnoses were upgraded honestly rather than denied; KPIs disclosed (newness penetration moving from 23% to 35%, full-price progression by quarter) were specific and falsifiable; and the company kept investing in long-term initiatives (international, optimization, marketing) rather than gutting them to defend near-term margin. Not higher because: the same management team has now offered three "root cause" diagnoses in eighteen months for the same problem, missed the centerpiece five-year plan, and exits during a transition led by an interim Co-CEO structure with a contested Board. Each future commitment will be discounted by a wider band than was warranted before FY2024.

6. What the Story Is Now

The current story is simpler than it was, but for unfortunate reasons. The growth narrative ("double the company in five years, drive U.S. through innovation, scale international, expand margin") has been replaced by a defense-and-rebuild narrative ("restore full-price discipline, manage tariffs, find a new CEO, get product right by 2026"). The stretch is no longer in the destination — it is in the timeline.

Three things to believe and three to discount, based on the evidence:

Believe:

• The international business is real, profitable, and growing at the rates management describes. China contributed strong incremental margin even in FY2025.
• The product organization changes (Cheung as Creative Director, planned 35% newness penetration in spring 2026, 12–14 month go-to-market) are concrete and falsifiable.
• The balance sheet absorbs the noise. Buybacks at FY2025 prices ($188 average in Q4) bought genuine value if the U.S. eventually inflects.

Discount:

• "Inflection in H2 2026" — the third such timeline in eighteen months.
• Any operating-margin expansion claim before FY2027. Management has stopped making one.
• The implicit assumption that the new CEO (not yet hired as of March 2026) inherits a stable plan. With a Wilson proxy contest underway and the Board adding both Chip Bergh and losing David Mussafer, the leadership picture is more contested than the headline reads.